Lance Converse

PurpleLab is a healthtech company focused on driving decisive action based on precise insights from real-world data. The company’s sophisticated HIPAA-compliant analytics platform, proven domain expertise and wealth of transactional and novel RWD, empowers healthcare stakeholders with the real-world evidence they need to solve conventional, new, and emerging challenges. With PurpleLab clients can derive value faster, more cost effectively, and with significantly greater confidence. Our highly experienced experts conform billions of raw claims and clinical healthcare transactions using our proprietary platform, HealthNexus™. We semantically harmonize critical events and relationships between data types at scale, making them analytics-ready. With integrated insights on de-identified patients, providers and payers clients receive ongoing objective, quantitative, predictive, and ad hoc real-world evidence to meet their business objectives. These include diagnosis, medications, procedures, measurements, observations and indications. PurpleLab continues to grow its data warehouse with trusted data partners across the healthcare ecosystem.

Your path to whole-body health begins with Totuum, where science meets nature. Founded by experts in pharmaceuticals and nutraceuticals, we’ve created a patented formula in collaboration with Duke University to support metabolic, brain, and liver health. After 8 years of research, our all-natural products are finally here! Were welcoming Motus, our metabolic health supplement, and Nouro, our state-of-the-art cognitive function supplement to the world in late Q1 2025. Totuum Health is owned by Prostasis LLC.

Totuum Health (formerly Prostasis) is revolutionizing what whole health means, with two new powerful natural products at the forefront of metabolic and brain health. After undergoing extensive research at Duke University for over 8 years, Totuum is gearing up to launch our hero products: motus, for weight loss, and nouro, for brain health. Available soon at totuumhealth.com

Crosstree is a distinguished boutique investment banking firm focused exclusively on the needs of middle-market companies within three subsectors of the life sciences and healthcare industries: pharmaceutical services, diagnostics and tools, and digital health. Since 2004, Crosstree has advised on more completed transactions in these collective subsectors than any other investment bank. The firm provides clients a full suite of advisory and capital raising services, including both buy-and sell-side mergers and acquisitions advisory, private capital raising, strategic advisory, and valuations. Crosstrees narrow industry focus provides clients the expertise common of a bulge-bracket investment banking firm to middle-market companies and investors, with unparalleled industry insights, well-established strategic relationships across the globe and superior access to capital markets. From our offices in Tampa, Florida, Crosstree has advised clients throughout North America, Europe, India, China, Latin America, and Australia on transactions ranging from $25 million to more than $1 billion. All securities transactions are offered by and conducted through Crosstree Capital Securities, LLC, a broker-dealer registered with the SEC, a member of FINRA (www.finra.org) and SIPC (www.sipc.org), and an affiliate of Crosstree Capital Partners, Inc.

PurpleLab is a healthtech company focused on driving decisive action based on precise insights from real-world data. The company’s sophisticated HIPAA-compliant analytics platform, proven domain expertise and wealth of transactional and novel RWD, empowers healthcare stakeholders with the real-world evidence they need to solve conventional, new, and emerging challenges. With PurpleLab clients can derive value faster, more cost effectively, and with significantly greater confidence. Our highly experienced experts conform billions of raw claims and clinical healthcare transactions using our proprietary platform, HealthNexus™. We semantically harmonize critical events and relationships between data types at scale, making them analytics-ready. With integrated insights on de-identified patients, providers and payers clients receive ongoing objective, quantitative, predictive, and ad hoc real-world evidence to meet their business objectives. These include diagnosis, medications, procedures, measurements, observations and indications. PurpleLab continues to grow its data warehouse with trusted data partners across the healthcare ecosystem.

Diasome Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering hepatocyte cell drug targeting to restore hepatocyte metabolism and treat metabolic diseases. Diasomes Hepatocyte Targeting Platform reestablishes hepatocyte function, addressing the root cause of dysregulations central to major metabolic diseases such as diabetes, obesity, and dyslipidemia. Diasome aims to deliver superior patient outcomes and enhanced disease management by leveraging the hepatocytes natural regulatory functions.